Exclusive

Publication

Byline

Location

Intellia To Report Phase 3 HAELO Topline Data For Lonvo-z On April 27; Stock Up

India, April 25 -- Intellia Therapeutics (NTLA) will release topline results from its global Phase 3 HAELO clinical trial evaluating Lonvoguran ziclumeran (lonvo-z) for hereditary angioedema on April ... Read More


U.S. Dollar Drops Against Majors

India, April 25 -- The U.S. dollar fell against its major counterparts in the New York session on Friday. The greenback fell to a 2-day low of 1.1723 against the euro and a 4-day low of 1.3538 agains... Read More


Canadian Market Recovers After Mild Setback

India, April 24 -- After a slightly positive start the Canadian market slipped into negative territory Friday morning, and despite coming off lower levels, remained in negative territory a little befo... Read More


Vistin Reports First Quarter 2026 Results

India, April 24 -- Vistin Pharma ASA (VISTN), a pharmaceutical manufacturing company, announced on Friday financial results for the first quarter of 2026. Vistin produces an estimated 10% of the worl... Read More


HCA Healthcare Stock Falls 8% Despite Q1 Earnings And Revenue Growth

India, April 24 -- HCA Healthcare, Inc. (HCA) declined 7.95 percent to $436.37, down $37.67 on Friday, even as the company reported higher first-quarter earnings and revenue. The company posted net i... Read More


Charter Communications Stock Falls 21% As Q1 Revenue Declines

India, April 24 -- Charter Communications, Inc. (CHTR) shares plunged 21.16 percent to $190.62, down $51.16 on Friday, as the company reported a decline in first-quarter revenue despite higher earning... Read More


Nasdaq Rebounds To New Record Intraday High As Intel Soars

India, April 24 -- Stocks have moved mostly higher during trading on Friday, largely offsetting the weakness seen in the previous session. With the rebound on the day, the tech-heavy Nasdaq has reache... Read More


Novartis' Itvisma Moves Closer To EU Approval With Positive CHMP Opinion

India, April 24 -- Novartis (NVS) has received a positive opinion from the European Medicines Agency's CHMP for Itvisma, bringing the one-time gene replacement therapy a step closer to approval for ol... Read More


Sensient Technologies Stock Gains 14% Over Higher Earnings In Q1

India, April 24 -- Stock of Sensient Technologies Corporation (SXT) is moving up about 14 percent on Friday morning trading after the company announced first-quarter earnings of $44.17 million, or $1.... Read More


U.S. Consumer Sentiment Index Upwardly Revised But Remains At Record Low In April

India, April 24 -- Revised data released by the University of Michigan on Friday showed consumer sentiment in the U.S. deteriorated by less than previously estimated in April but still hit a record lo... Read More